{"id":231007,"date":"2026-09-04T11:30:42","date_gmt":"2026-09-04T06:00:42","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=231007"},"modified":"2026-09-04T11:30:45","modified_gmt":"2026-09-04T06:00:45","slug":"aarti-pharmalabs-share-price-buy-hold-or-sell","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/aarti-pharmalabs-share-price-buy-hold-or-sell\/","title":{"rendered":"Aarti Pharmalabs: Should You Buy, Hold, or Sell Right Now?"},"content":{"rendered":"

Aarti Pharmalabs share price Rs 874 (NSE), roughly flat today. 52-week range Rs 585 to Rs 946.10. Q1 FY27 revenue up 38.3% YoY, profit up 53.8% YoY.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Aarti Pharmalabs Ltd share price is trading around Rs 874, roughly 8 percent below its 52-week high of Rs 946.10 but well above its 52-week low of Rs 585. Q1 FY27 revenue grew a strong 38.3 percent year on year to Rs 536.25 crore, with net profit up 53.8 percent to Rs 76.14 crore, continuing consistent growth for this pharma intermediates and API manufacturer, which was spun off from Aarti Industries. Full-year FY25 profit grew 25.6 percent to Rs 272.4 crore. The stock trades at 36.8 times earnings, roughly in line with the pharma sector average near 38 times.<\/p>\n<\/div>\n

Aarti Pharmalabs share price is trading close to its 52-week high of Rs 946.10, with Aarti Pharmalabs share price near Rs 874 on the NSE, well above its 52-week low of Rs 585. With strong growth in Q1 FY27, investors are asking whether this pharma intermediates manufacturer is a stock to buy near its highs, a hold, or a sell.<\/p>\n

This Aarti Pharmalabs stock analysis walks through the Q1 FY27 numbers, valuation against the pharma sector, shareholding pattern and the technical setup, using figures sourced from company disclosures and public filings.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n